Evidence map›Paper›PMID 42354925›Full record

ArticleMicroorganisms2026

Strengthening STD Screening Programs: Comprehensive Evaluation of High-Throughput Immunoassays for HIV and Syphilis Detection.

Ahmed Ismail, Shaden Abunasser, Israa M Salameh, Mazen Najib Abouassali, Manal Elshaikh, Ibrahim Wissam Karimeh, Mohammed Abdelfatah Ibrahim, Mutaz Mohamed Ali, Ibrahim Al Shaar, Parveen Banu Nizamuddin and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ahmed IsmailLaboratory Section, Medical Commission Department, Ministry of Public Health, Doha 42, Qatar.ORCID 0000-0003-0102-8155
Shaden AbunasserDepartment of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar.
Israa M SalamehBiomedical Research Center, Qatar University, Doha 2713, Qatar.
Mazen Najib AbouassaliLaboratory Section, Medical Commission Department, Ministry of Public Health, Doha 42, Qatar.
Manal ElshaikhLaboratory Section, Medical Commission Department, Ministry of Public Health, Doha 42, Qatar.
Ibrahim Wissam KarimehLaboratory Section, Medical Commission Department, Ministry of Public Health, Doha 42, Qatar.
Mohammed Abdelfatah IbrahimLaboratory Section, Medical Commission Department, Ministry of Public Health, Doha 42, Qatar.
Mutaz Mohamed AliLaboratory Section, Medical Commission Department, Ministry of Public Health, Doha 42, Qatar.
Ibrahim Al ShaarLaboratory Section, Medical Commission Department, Ministry of Public Health, Doha 42, Qatar.
Parveen Banu NizamuddinBiomedical Research Center, Qatar University, Doha 2713, Qatar.
Salma YounesDepartment of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar.
Hadi M YassineDepartment of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar.
Laith J Abu-RaddadInfectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha 24144, Qatar.ORCID 0000-0003-0790-0506
Nadin YounesDepartment of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar.ORCID 0000-0002-5241-944X
Gheyath K NasrallahDepartment of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar.ORCID 0000-0001-9252-1038

Funding

qatar national research fund UREP30-041-3-014Qatar National Research Fund GSRA8-L-1-0501-21022Qatar National Research Fund NPRP13S-0128-200185
6 · The paper itself

Abstract

Fourth-generation immunoassays are widely used for HIV and syphilis screening; however, false-reactive results may increase confirmatory testing and operational burden in high-throughput laboratories. This study evaluated the comparative performance of automated chemiluminescent immunoassays (MAGLUMI

Indexed as

ARCHITECTchemiluminescent immunoassaydiagnosticsHIVINNO-LIAMAGLUMIPCRpublic healthRPRscreeningsyphilisVITROS

Identifiers

PMID42354925
PMCPMC13304136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.